Quancheng Kan
- Topics
- Metabolism and Genetic Disorders (3 papers)Pain Management and Opioid Use (2 papers)Mitochondrial Function and Pathology (2 papers)
- Journals
- Journal of Controlled ReleaseArchives of Biochemistry and BiophysicsInflammatory Bowel Diseases
- Partner nations
- ChinaUnited States
In The Last Decade
Quancheng Kan
17 papers receiving 326 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 122
- Immunology 79
- Biomaterials 41
- Epidemiology 37
- Physiology 33
Countries citing papers authored by Quancheng Kan
This map shows the geographic impact of Quancheng Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quancheng Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quancheng Kan more than expected).
Fields of papers citing papers by Quancheng Kan
This network shows the impact of papers produced by Quancheng Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quancheng Kan. The network helps show where Quancheng Kan may publish in the future.
Co-authorship network of co-authors of Quancheng Kan
This figure shows the co-authorship network connecting the top 25 collaborators of Quancheng Kan. A scholar is included among the top collaborators of Quancheng Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quancheng Kan. Quancheng Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 57 | |
| 3 | 5 | |
| 4 | 12 | |
| 5 | 4 | |
| 6 | 23 | |
| 7 | Lowering blood ammonia prevents hepatocyte injury and apoptosis. | 11 |
| 8 | 27 | |
| 9 | 5 | |
| 10 | 22 | |
| 11 | 9 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 32 | |
| 15 | 2 | |
| 16 | A pilot study for a pivotal bioequivalence trial using two paroxetine 40 mg tablet formulations in healthy Chinese subjects | 0 |
| 17 | 34 | |
| 18 | 78 |
About Quancheng Kan
Quancheng Kan is a scholar working on Clinical Biochemistry, Biological Psychiatry and Anesthesiology and Pain Medicine, having authored 18 papers that have together received 332 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (3 papers), Pain Management and Opioid Use (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Clinical Biochemistry (29 citations), Anesthesiology and Pain Medicine (22 citations) and Immunology (79 citations). Quancheng Kan has collaborated with scholars based in China and United States. Frequent co-authors include Guang‐Xian Zhang, Lin Zhu, Nan Liu, Yulan Liu, Chuanyong Guo, Yi Cui, Yang Li, Xingpeng Wang, Zhigang Huang and Zhanju Liu. Their work appears in journals such as Journal of Controlled Release, Archives of Biochemistry and Biophysics and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.